Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

Subjects:

Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

Subjects:

Contains R code utilized in the analyses. by Arttu Autio-Kimura (20454681)

Subjects:

Sex-based differences for combinations of brain regions and cell types, based on Mann-Whitney U-test. by Arttu Autio-Kimura (20454681)

Subjects:

Bootstrapped spearman correlations from a randomly selected subset of male sample donor originating samples (n = 493). by Arttu Autio-Kimura (20454681)

Subjects:

Spearman correlations between the age of the sample donor (20–70 years) and estimated proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Box plots for subsets of female originating samples, displaying the distributions of the proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Box plots for subsets of male originating samples, displaying the distributions of the proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Box plot displaying the distributions of the deconvolution derived proportions of cell types. by Arttu Autio-Kimura (20454681)

Subjects:

Spearman correlation of age with proportions of cell types in men, for each brain region. by Arttu Autio-Kimura (20454681)

Subjects:

Principal Component Analysis (PCA) to illustrate the distribution of the significant lipid metabolites among the groups (NL, SS and MASH). by Laia Bertran (3685147)

Integration of Metabolomics, Transcriptomics, and 16s rRNA Sequencing Reveals the Mechanism of Morus alba <i>L.</i> (Sangzhi) Alkaloids (SZ-A) in Improving Cholesterol Metabolism i... by Caina Li (4126462)

Subjects:

Effects of compound 4f on neuroinflammation in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

Top 20 IPA pathways of 2405 genes downregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Subjects:

All data in the manuscript and supporting information. by Naoto Arimura (416442)

Subjects:

The effects of cannabinoid receptor antagonists against neuroprotective effects of compound 4f in KA-treated mice. by Naoto Arimura (416442)

Subjects:

Representative image data in Fig 5. by Naoto Arimura (416442)

Subjects:

Pharmacokinetics and pharmacodynamics of compound 4f in mice. by Naoto Arimura (416442)

Subjects:

Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

Top 20 Ingenuity Pathway Analysis (IPA) pathways of 3382 genes upregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Subjects: